BeStock  

LeMaitre Vascular LMAT

US equityMarket cap rank #2835Medical Instruments & Supplies
$80.99 +$2.03 (+2.57%)
Pre-market · Oct 6, 7:40 am ET · After hours $80.99 0.00%
Open$79.00
Prev close$78.96
Day range$78.49 – $81.83
Volume369.8K
Market cap$1.85B
P/E (TTM)28.3
Dividend yield1.11%

Balance sheet

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Total Current Liabilities $36.32M $30.61M $29.88M $25.33M $21.81M
-Gross PPE $71.16M $65.78M $61.27M $58.66M $55.06M
-Accumulated Depreciation -$28.40M -$24.22M -$21.49M -$25.12M -$22.93M
Goodwill and Other Intangible Assets $99.03M $101.76M $107.66M $112.47M $118.66M
-Goodwill $65.95M $65.95M $65.95M $65.95M $65.95M
-Other Intangible Assets $33.09M $35.82M $41.71M $46.53M $52.71M
Non-Current Deferred Assets $759,000.00 $1.43M $1.00M $1.75M $1.57M
Other Non-Current Assets $4.91M $4.87M $3.74M $991,000.00 $568,000.00
Total Liabilities $222.17M $214.53M $48.88M $42.28M $38.65M
Payables $23.59M $17.52M $17.48M $14.12M $13.13M
Net PPE $42.76M $41.57M $39.78M $33.54M $32.13M
Total Non-Current Assets $147.46M $149.63M $152.18M $148.74M $152.92M
Total Assets $615.69M $551.82M $346.78M $310.48M $292.80M
Total Current Assets $468.23M $402.19M $194.60M $161.73M $139.88M
-Cash and Cash Equivalents $28.24M $25.61M $24.27M $19.13M $13.86M
-Short Term Investments $330.88M $274.11M $80.81M $63.56M $56.10M
Receivables $33.61M $30.06M $25.06M $22.04M $19.63M
-Accounts Receivable $33.61M $30.06M $25.06M $22.04M $19.63M
Inventory $58.25M $55.94M $52.33M $45.28M $40.65M
Current Deferred Assets $12.18M $8.99M $5.75M $4.99M $5.46M
Other Current Assets $5.08M $7.48M $6.38M $6.73M $4.19M
-Accounts Payable $3.65M $1.76M $3.73M $2.90M $2.34M
-Total Tax Payable $19.95M $15.76M $13.74M $11.22M $10.79M
Total Equity $393.52M $337.29M $297.90M $268.20M $254.15M
Stockholders' Equity $393.52M $337.29M $297.90M $268.20M $254.15M
Capital Stock $244,000.00 $242,000.00 $239,000.00 $237,000.00 $235,000.00
-Common Stock $244,000.00 $242,000.00 $239,000.00 $237,000.00 $235,000.00
Gains/Losses Not Affecting Retained Earnings -$2.41M -$6.18M -$4.63M -$6.03M -$3.44M
Less: Treasury Stock $17.44M $15.62M $13.90M $13.05M $12.40M
Retained Earnings $184.72M $145.09M $115.43M $97.77M $88.13M
Additional Paid-In Capital $228.41M $213.76M $200.76M $189.27M $181.63M
Other Non-Current Liabilities $964,000.00 $259,000.00 $1.63M $1.53M $1.90M
Non-Current Deferred Liabilities $1.74M $85,000.00 $107,000.00 $69,000.00 $70,000.00
Current Accrued Expenses $9.46M $8.98M $9.91M $8.75M $5.55M
Short-Term Debt and Capital Lease Obligation $2.94M $2.68M $2.47M $1.89M $1.87M
-Current Capital Lease Obligation $2.94M $2.68M $2.47M $1.89M $1.87M
Other Current Liabilities $322,000.00 $1.43M $24,000.00 $573,000.00 $1.27M
Total Non-Current Liabilities $185.85M $183.92M $19.00M $16.95M $16.84M
Long Term Accounts Payable and Other Payables $504,000.00 $572,000.00 $637,000.00 $636,000.00 $799,000.00
Long Term Debt and Capital Lease Obligation $182.65M $183.00M $16.62M $14.71M $14.07M
-Long Term Debt $168.65M $167.77M – – –
-Long Term Capital Lease Obligation $14.00M $15.23M $16.62M $14.71M $14.07M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Cash and Cash Equivalents & Short-Term Investments $359.12M $299.72M $105.07M $82.69M $69.96M

Cash flow

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Free Cash Flow $74.47M $37.16M $29.49M $22.15M $30.22M
Effect of Exchange Rate Changes $864,000.00 -$765,000.00 $230,000.00 -$494,000.00 -$637,000.00
-Change in Payables and Accrued Expense $6.00M -$779,000.00 $4.60M $645,000.00 -$1.73M
-Change in Prepaid Assets $2.43M -$2.33M -$2.92M -$3.10M -$1.93M
-Change in Inventory -$7.22M -$10.57M -$9.79M -$7.42M -$5.49M
-Change in Receivables -$2.95M -$6.42M -$3.14M -$3.53M -$818,000.00
Change in Working Capital -$1.75M -$20.10M -$11.25M -$13.40M -$9.96M
Other Non-Cash Items $873,000.00 $196,000.00 -$78,000.00 -$108,000.00 -$674,000.00
Deferred Tax $2.31M -$451,000.00 $783,000.00 -$182,000.00 $79,000.00
Depreciation & Depletion & Amortization $10.42M $9.61M $9.52M $9.43M $11.07M
Gain/Loss from Continuing Operations -$176,000.00 $362,000.00 -$220,000.00 $1.62M $163,000.00
Net cash flow from continuing operations $81.25M $44.12M $36.75M $25.38M $35.10M
Net Income from Continuing Operations $57.73M $44.04M $30.11M $20.64M $26.91M
Operating Cash Flow $81.25M $44.12M $36.75M $25.38M $35.10M
Net cash flow from investing -$64.94M -$200.12M -$24.72M -$10.37M -$61.08M
Net Cash Flow from Continuing Investing Activities -$64.94M -$200.12M -$24.72M -$10.37M -$61.08M
Net Other Financing Charges -$1.43M -$1.51M – -$1.07M -$401,000.00
Net Change in Cash $1.77M $2.11M $4.91M $5.77M -$12.27M
Ending Cash Balance $28.24M $25.61M $24.27M $19.13M $13.86M
Proceeds from Stock Option Exercised $5.00M $4.72M $5.32M -$642,000.00 -$802,000.00
Cash Dividends Paid -$18.11M -$14.38M -$12.45M -$10.99M -$9.34M
Net Issuance Payments Of Debt $0.00 $169.27M $0.00 $0.00 -$39.00M
Net Cash Flow from Continuing Financing Activities -$14.54M $158.10M -$7.13M -$9.23M $13.70M
Financing Cash Flow -$14.54M $158.10M -$7.13M -$9.23M $13.70M
Net Investment Purchase and Sale -$56.26M -$193.16M -$16.55M -$8.00M -$56.19M
Net Business Purchase and Sale -$1.90M $0.00 -$899,000.00 $0.00 $0.00
Net PPE Purchase and Sale -$6.78M -$6.96M -$7.27M -$2.37M -$4.88M
Beginning Cash Balance $25.61M $24.27M $19.13M $13.86M $26.76M
Net Common Stock Issuance – – – $3.47M $63.24M

Discussion

No comments yet — be the first to weigh in on LMAT.

Leave a comment

Scroll to Top